Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting

OBJECTIVES: Mobility impairments constitute a long-term burden in patients with multiple sclerosis (MS). Currently there is evidence that the drug fampridine may improve nonwalking symptoms in MS patients. The main objective of this study is to analyze whether participants showing a beneficial walki...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Chronic Dis
Main Authors: Rodriguez-Leal, Francisco Alejandro, Haase, Rocco, Akgün, Katja, Eisele, Judith, Proschmann, Undine, Schultheiss, Thorsten, Kern, Raimar, Ziemssen, Tjalf
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6475844/
https://ncbi.nlm.nih.gov/pubmed/31037211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622319835136
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados